Close Menu

technology development

IBM and the Broad Institute will codevelop algorithms to apply artificial intelligence to predict cardiovascular risk from genomic and clinical data.

The R&D collaboration will examine a Western Digital theory that moving computational power closer to large genomic datasets can speed up analysis.

By partnering with telehealth provider PWNHealth, Lineagen wants to help children on the autism spectrum start treatment faster and qualify for more benefits.

LunaDNA parent company LunaPBS will combine its technology platform with Genetic Alliance's PEER system to advance patient-centric research.

This embargo-free strategy represents "an entirely new way of doing research" into rare pediatric cancers, where time is of the essence.

Run by the daughter of a renowned genetic oncologist, CancerIQ is expanding and raising money as it rolls out its testing management and clinical decision support technology.

With the recent introduction of its Reveal platform, the company behind the 1000 Genomes Project browser wants to unlock the potential of the UK Biobank dataset.

HudsonAlpha's Genome Gateway collects family histories and facilitates secure communication between patients, clinicians, and researchers.

The Menlo Park, California-based company plans to demonstrate its sequencing technology on a small genome in the near future.

Finland-based Tieto and Swiss firm BC Platforms will jointly develop technology for integrating genomic and clinical data in the Northern European market.

Pages

Nature News writes that additional details about the UK plan for an agency to support high-risk, high-reward science are needed.

The New York Times reports that the US Food and Drug Administration has authorized Johnson & Johnson's SARS-CoV-2 vaccine.

The Wall Street Journal writes new studies are giving glimpses into the origins of SARS-CoV-2.

In PLOS this week: analysis of Plasmodium population structure, qPCR assay to diagnose scabies, and more.